I agree that this site is using cookies. You can find further informations
here
.
X
Login
Merkliste (
0
)
Home
About us
Home About us
Our history
Profile
Press & public relations
Friends
The library in figures
Exhibitions
Projects
Training, internships, careers
Films
Services & Information
Home Services & Information
Lending and interlibrary loans
Returns and renewals
Training and library tours
My Account
Library cards
New to the library?
Download Information
Opening hours
Learning spaces
PC, WLAN, copy, scan and print
Catalogs and collections
Home Catalogs and Collections
Rare books and manuscripts
Digital collections
Subject Areas
Our sites
Home Our sites
Central Library
Law Library (Juridicum)
BB Business and Economics (BB11)
BB Physics and Electrical Engineering
TB Engineering and Social Sciences
TB Economics and Nautical Sciences
TB Music
TB Art & Design
TB Bremerhaven
Contact the library
Home Contact the library
Staff Directory
Open access & publishing
Home Open access & publishing
Reference management: Citavi & RefWorks
Publishing documents
Open Access in Bremen
zur Desktop-Version
Toggle navigation
Merkliste
1 Ergebnisse
1
Outcome of AML patients with IDH2 mutations in real world b..:
Largeaud, Laetitia
;
Bérard, Emilie
;
Bertoli, Sarah
...
info:eu-repo/semantics/altIdentifier/doi/10.1016/j.leukres.2019.04.010. , 2019
Link:
https://hal.science/hal-03480701
RT Journal T1
Outcome of AML patients with IDH2 mutations in real world before the era of IDH2 inhibitors
UL https://suche.suub.uni-bremen.de/peid=base-ftinserm:oai:HAL:hal-03480701v1&Exemplar=1&LAN=DE A1 Largeaud, Laetitia A1 Bérard, Emilie A1 Bertoli, Sarah A1 Dufrechou, Stéphanie A1 Prade, Naïs A1 Gadaud, Noémie A1 Tavitian, Suzanne A1 Bories, Pierre A1 Luquet, Isabelle A1 Sarry, Audrey A1 de Mas, Véronique A1 Huguet, Françoise A1 Delabesse, Eric A1 Récher, Christian PB HAL CCSD; Elsevier YR 2019 K1 AML K1 Enasidenib K1 IDH K1 Refractory K1 Relapse K1 MESH: Adult K1 MESH: Aged K1 MESH: Leukemia K1 Myeloid K1 Acute / mortality K1 Acute / pathology K1 MESH: Antineoplastic Combined Chemotherapy Protocols / therapeutic use K1 MESH: Drug Resistance K1 Neoplasm / drug effects K1 MESH: Female K1 MESH: Follow-Up Studies K1 MESH: Humans K1 MESH: Isocitrate Dehydrogenase / genetics K1 Acute / drug therapy K1 Acute / genetics K1 [SDV.MHEP]Life Sciences [q-bio]/Human health and pathology JF info:eu-repo/semantics/altIdentifier/doi/10.1016/j.leukres.2019.04.010 LK http://dx.doi.org/https://hal.science/hal-03480701 DO https://hal.science/hal-03480701 SF ELIB - SuUB Bremen
Export
RefWorks (nur Desktop-Version!)
Flow
(Zuerst in
Flow
einloggen, dann importieren)